In a previous report, hemin treatment to breast cancer cells and the mice bearing breast tumors exhibited substantially reduced BACH1 levels with unnoticeable toxicity, suggesting hemin as a potentially non-toxic BACH1-specific drug for tumors [10]. This evidence concerns the gene BACH1 and breast carcinoma.